HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G’s Leaner, Stronger Beauty Business Drives 10% Growth

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble beauty sector sales grow 10% in its latest quarter on strength of anti-aging skin care products globally and across price tiers. Firm also announces to purchase First Aid Beauty, further diversifying its skin care portfolio with a lineup of products sold in specialty retail stores and priced between P&G's SK-II and Olay brands.

You may also be interested in...



Unilever Grows European Portfolio, P&G Trims More Brands In Toothpaste Deal

Fluocaril and Parogencyl are “well-known” toothpastes that have garnered “strong endorsement from health professionals,” Unilever says. The brands, identified by analysts as potential candidates for sale, are latest in P&G’s ongoing trimming of lower-selling lines.

P&G Broad-Based Beauty Business Bounce Behind 4% Overall Sales Growth

P&G reported total beauty division sales grew 5% to $3.29bn, with a 20% jump in SK-II offset somewhat by low single-digit growth in hair care. Investors rewarded the firm’s better-than-expected net sales results with same-day 9% bump in its share price.

P&G's OTC Market Direction Steered By Consumers' Turn To Self-Care Solutions

Firm scans health care market for OTC drug properties meeting consumers’ growing demand for non-Rx products, says CFO Jon Moeller. He says P&G is well-positioned to "brand-build" acquired assets given its distribution network in oral, personal and feminine care, and its cost-cutting capabilities.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel